Invitrogen

The Invitrogen AG (former symbol NASDAQ: IVGN ) was a large multinational biotechnology company based in Carlsbad, California, USA. In November 2008, merged with Invitrogen Life Technologies Applied Biosystems to.

History

Invitrogen was founded in 1987 by Lyle Turner, Joe Fernandez and Willian McConnell, who let their company registered as a limited company in 1989.

The company celebrated its first success with sets for molecular cloning, in particular with the product " The Librarian " (for the preparation of cDNA libraries), and " Fast Track Kit" ( for mRNA isolation from biological samples ).

In 1998, the company reported revenue of 33 million U.S. dollars and went public in 1999. As a result, Novatech has been adopted, a leader for the characterization of cloned proteins. It was followed by the purchase of ResGen, a specialist in genomics and synthetic DNA chemistry.

The business was expanded considerably in 2000, as Invitrogen acquired the competing company Life Technologies / GIBCO. A multitude of other mergers and acquisitions (eg Molecular Probes, Panvera and BioSource ) broadened the company 's customer base and strengthened its portfolio of intellectual property ( patents).

Through the merger with Applied Biosystems, a maker of DNA sequencing and PCR machines, Invitrogen has doubled its size. Despite the renaming of the company in the Life Technologies brand Invitrogen, Gibco and Applied Biosystems continue to be used in the sale.

Products and technologies

  • Dynabeads magnetic separation method
  • Reverse transcriptase as the Superscript
  • The thermostable DNA polymerases such as Platinum TAQ
  • TOPO cloning
  • Fluorescent dyes such as quantum dot nanocrystals AlexaFluor, SYBR
415610
de